ASAH1_HUMAN - dbPTM
ASAH1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ASAH1_HUMAN
UniProt AC Q13510
Protein Name Acid ceramidase
Gene Name ASAH1
Organism Homo sapiens (Human).
Sequence Length 395
Subcellular Localization Lysosome.
Protein Description Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid..
Protein Sequence MPGRSCVALVLLAAAVSCAVAQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPVLKVIVNSLKNMINTFVPSGKIMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELFTICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDVMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
39PhosphorylationRKSTYPPSGPTYRGA
HHCCCCCCCCCCCCC
53.55-
42PhosphorylationTYPPSGPTYRGAVPW
CCCCCCCCCCCCCCE
29.40-
43PhosphorylationYPPSGPTYRGAVPWY
CCCCCCCCCCCCCEE
15.35-
86PhosphorylationSLKNMINTFVPSGKI
HHHHHHHHHCCCCCH
18.3221406692
90PhosphorylationMINTFVPSGKIMQVV
HHHHHCCCCCHHHHH
47.6321406692
92 (in isoform 1)Ubiquitination-39.0721890473
92UbiquitinationNTFVPSGKIMQVVDE
HHHCCCCCHHHHHCC
39.072189047
100UbiquitinationIMQVVDEKLPGLLGN
HHHHHCCCCCCHHCC
56.36-
108 (in isoform 2)Ubiquitination-7.6021890473
123PhosphorylationMKGIAAVTDIPLGEI
HCCEEEEECCCHHHH
24.3922210691
132PhosphorylationIPLGEIISFNIFYEL
CCHHHHHHHHHHHHH
20.2222210691
137PhosphorylationIISFNIFYELFTICT
HHHHHHHHHHHHHHH
14.1322210691
173N-linked_GlycosylationFLGWNINNDTWVITE
EEEEEECCCEEEEEE
44.2729692406
195N-linked_GlycosylationNLDFQRNNKTVFKAS
EEECCCCCCEEEEEH
43.49UniProtKB CARBOHYD
197PhosphorylationDFQRNNKTVFKASSF
ECCCCCCEEEEEHHH
33.04-
202PhosphorylationNKTVFKASSFAGYVG
CCEEEEEHHHHHHHH
26.95-
253PhosphorylationVMWIGFLTRTVLENS
EEEHHHHHHHHHHCC
23.25-
255PhosphorylationWIGFLTRTVLENSTS
EHHHHHHHHHHCCCC
24.98-
259N-linked_GlycosylationLTRTVLENSTSYEEA
HHHHHHHCCCCHHHH
46.5616263699
272UbiquitinationEAKNLLTKTKILAPA
HHHHHHHHHHEEECE
48.03-
273PhosphorylationAKNLLTKTKILAPAY
HHHHHHHHHEEECEE
20.3430576142
280PhosphorylationTKILAPAYFILGGNQ
HHEEECEEEECCCCC
7.0630576142
286N-linked_GlycosylationAYFILGGNQSGEGCV
EEEECCCCCCCCCEE
30.9212754519
295PhosphorylationSGEGCVITRDRKESL
CCCCEEEECCCCCCE
13.2030576142
299UbiquitinationCVITRDRKESLDVYE
EEEECCCCCCEEEEE
56.81-
301PhosphorylationITRDRKESLDVYELD
EECCCCCCEEEEEEE
32.6723312004
305PhosphorylationRKESLDVYELDAKQG
CCCCEEEEEEECCCC
15.50-
310UbiquitinationDVYELDAKQGRWYVV
EEEEEECCCCCEEEE
53.61-
342N-linked_GlycosylationTPAKMCLNRTSQENI
CCHHHHCCCCCCCCC
40.0129692406
348N-linked_GlycosylationLNRTSQENISFETMY
CCCCCCCCCCHHHHH
27.80UniProtKB CARBOHYD
359PhosphorylationETMYDVLSTKPVLNK
HHHHHHHCCCHHHCC
33.94-
360PhosphorylationTMYDVLSTKPVLNKL
HHHHHHCCCHHHCCE
34.90-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ASAH1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ASAH1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ASAH1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SETB1_HUMANSETDB1physical
16169070
T22D1_HUMANTSC22D1physical
16169070
KCC1D_HUMANCAMK1Dphysical
21988832
NFH_HUMANNEFHphysical
26186194
KCC2B_HUMANCAMK2Bphysical
26186194
NONO_HUMANNONOphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
228000Farber lipogranulomatosis (FL)
159950Spinal muscular atrophy with progressive myoclonic epilepsy (SMAPME)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ASAH1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-259 AND ASN-286, AND MASSSPECTROMETRY.
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach.";
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
Mol. Cell. Proteomics 5:226-233(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-259, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-259, AND MASSSPECTROMETRY.
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry.";
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
Nat. Biotechnol. 21:660-666(2003).
Cited for: GLYCOSYLATION AT ASN-259 AND ASN-286.

TOP